BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25627979)

  • 1. Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle.
    Peiris PM; Abramowski A; Mcginnity J; Doolittle E; Toy R; Gopalakrishnan R; Shah S; Bauer L; Ghaghada KB; Hoimes C; Brady-Kalnay SM; Basilion JP; Griswold MA; Karathanasis E
    Cancer Res; 2015 Apr; 75(7):1356-65. PubMed ID: 25627979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crossing the barrier: treatment of brain tumors using nanochain particles.
    Karathanasis E; Ghaghada KB
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):678-95. PubMed ID: 26749497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
    Karim R; Palazzo C; Evrard B; Piel G
    J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smart multifunctional core-shell nanospheres with drug and gene co-loaded for enhancing the therapeutic effect in a rat intracranial tumor model.
    Wang H; Su W; Wang S; Wang X; Liao Z; Kang C; Han L; Chang J; Wang G; Pu P
    Nanoscale; 2012 Oct; 4(20):6501-8. PubMed ID: 22961067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-pot synthesis of nanochain particles for targeting brain tumors.
    Perera VS; Covarrubias G; Lorkowski M; Atukorale P; Rao A; Raghunathan S; Gopalakrishnan R; Erokwu BO; Liu Y; Dixit D; Brady-Kalnay SM; Wilson D; Flask C; Rich J; Peiris PM; Karathanasis E
    Nanoscale; 2017 Jul; 9(27):9659-9667. PubMed ID: 28675230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors.
    Byeon HJ; Thao le Q; Lee S; Min SY; Lee ES; Shin BS; Choi HG; Youn YS
    J Control Release; 2016 Mar; 225():301-13. PubMed ID: 26826308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Dose and Selection of Two Different Ligands on the Deposition and Antitumor Efficacy of Targeted Nanoparticles in Brain Tumors.
    Turan O; Bielecki P; Tong K; Covarrubias G; Moon T; Rahmy A; Cooley S; Park Y; Peiris PM; Ghaghada KB; Karathanasis E
    Mol Pharm; 2019 Oct; 16(10):4352-4360. PubMed ID: 31442061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.
    Choudhury H; Pandey M; Chin PX; Phang YL; Cheah JY; Ooi SC; Mak KK; Pichika MR; Kesharwani P; Hussain Z; Gorain B
    Drug Deliv Transl Res; 2018 Oct; 8(5):1545-1563. PubMed ID: 29916012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
    Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
    J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
    Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
    J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-aggregated protamine-coated poly(lactide-co-glycolide) nanoparticles of cisplatin crossed blood-brain barrier, enhanced drug delivery and improved therapeutic index in glioblastoma cells: in vitro studies.
    Dhami NK; Pandey RS; Jain UK; Chandra R; Madan J
    J Microencapsul; 2014; 31(7):685-93. PubMed ID: 24963955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of glioblastoma with poly(isohexyl cyanoacrylate) nanoparticles.
    Wohlfart S; Khalansky AS; Bernreuther C; Michaelis M; Cinatl J; Glatzel M; Kreuter J
    Int J Pharm; 2011 Aug; 415(1-2):244-51. PubMed ID: 21641983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient delivery of docetaxel for the treatment of brain tumors by cyclic RGD-tagged polymeric micelles.
    Li AJ; Zheng YH; Liu GD; Liu WS; Cao PC; Bu ZF
    Mol Med Rep; 2015 Apr; 11(4):3078-86. PubMed ID: 25434368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of drugs into brain tumors using multicomponent silica nanoparticles.
    Turan O; Bielecki P; Perera V; Lorkowski M; Covarrubias G; Tong K; Yun A; Rahmy A; Ouyang T; Raghunathan S; Gopalakrishnan R; Griswold MA; Ghaghada KB; Peiris PM; Karathanasis E
    Nanoscale; 2019 Jun; 11(24):11910-11921. PubMed ID: 31187845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect.
    Wu J; Zhao J; Zhang B; Qian Y; Gao H; Yu Y; Wei Y; Yang Z; Jiang X; Pang Z
    Int J Nanomedicine; 2014; 9():5261-71. PubMed ID: 25419130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On-command drug release from nanochains inhibits growth of breast tumors.
    Peiris PM; Tam M; Vicente P; Abramowski A; Toy R; Bauer L; Mayer A; Pansky J; Doolittle E; Tucci S; Schmidt E; Shoup C; Rao S; Murray K; Gopalakrishnan R; Keri RA; Basilion JP; Griswold MA; Karathanasis E
    Pharm Res; 2014 Jun; 31(6):1460-8. PubMed ID: 23934254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nanostructure of functional targeting epirubicin liposomes dually modified with aminophenyl glucose and cyclic pentapeptide used for brain glioblastoma treatment.
    Zhang CX; Zhao WY; Liu L; Ju RJ; Mu LM; Zhao Y; Zeng F; Xie HJ; Yan Y; Lu WL
    Oncotarget; 2015 Oct; 6(32):32681-700. PubMed ID: 26418720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of blood-brain barrier-stealth nanocomposites for in situ glioblastoma theranostics applications.
    Su CH; Tsai CY; Tomanek B; Chen WY; Cheng FY
    Nanoscale; 2016 Apr; 8(15):7866-70. PubMed ID: 27035391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.